Showing posts with label 2017 Summary International Liver Congress. Show all posts
Showing posts with label 2017 Summary International Liver Congress. Show all posts

Sunday, April 23, 2017

Hep C 5-minute videos - Summary Of The International Liver Congress™ (ILC) 2017

Hep C Summary - The International Liver Congress™ (ILC) 2017

After each conference this blog links to a series of education-related information on important findings related to ongoing challenges of managing and treating viral hepatitis. Listed below are programs  reviewing key HCV data presented at the International Liver Congress™, with links to additional coverage.

Although the following video/lecture program is aimed at clinicians, it's pretty cut and dry; easy to comprehend. In addition Viral Ed will be launching an expert review of the meeting on May 1, 2017.

This page will be updated as new learning activities become available, with a dated reminder on the sidebar of this blog.

Hepatitis C - 5-minutes videos each day from The International Liver Congress™ available at Practice Point Hepatitis

In this video series, Dr. Tran will present "what you need to know in 5 minutes" offering us a quick review of  clinical studies on new antiviral therapy, data on drug toxicity/adverse events, drug interactions, and strategies for HCV management.

Free registration is required to view videos, sign up here...
After you register scroll down before clicking on "Access Video"

Main Menu
Click here to view videos each day from The International Liver Congress™ (ILC) 2017, 52nd annual meeting of the European Association for the Study of the Liver (EASL).

*This conference coverage is not sanctioned by the conference organizers (European Association for the Study of the Liver) and is not an official part of the conference proceedings from ILC 2017.

Video Highlights

Day One
Expedition-1 Glecaprevir/Pibrentasvir HCV Genotypes 1,2,4,5,6 and compensated cirrhosis
HCC reoccurrence after interferon-free therapy
Day Two
Endurance 3 Glecaprevir/Pibrentasvir treatment naïve genotype 3 without cirrhosis
HBV/HCV Coinfected - Ledipasvir/Sofosbuvir 12weeks
Real-World Observational Study in the U.S. Veterans Affairs System Evaluating Use of Merck’s (Elbasvir and Grazoprevir)
German Registry - SVR 12 rates with interferon-free therapies in advanced HCV-associated cirrhosis
Direct-acting antiviral treatment in children
Day Three
Magellan-1 Part 2:  Glecaprevir/Pibrentasvir  HCV Genotype 1 or 4 Prior DAA Failures
Magellan-2 Glecaprevir/Pibrentasvir  in liver or renal transplant recipients with HCV genotype 1-6 
Day Four
Re-treatment in HCV-associated cirrhosis
Begin here....

Coming Soon
May 1 over @ Viral Ed
The Advances in Chronic Hepatitis C: Management and Treatment program is a comprehensive, expert review of the 52nd Annual Meeting of the European Association for the Study of the Liver (EASL 2017). This program will feature HCV experts reviewing and discussing the most important studies on chronic hepatitis C presented at EASL 2017. This review and discussion will provide a comprehensive overview of each of the posters and presentations as selected by our faculty panel. In addition, the faculty will provide unique insights into how knowledgeable experts review and analyze data from EASL and an in-depth understanding of the scientific quality and clinical relevance of the posters and presentations reviewed.
Begin here......

ViralEd - Daily Highlights from EASL 2017

Helpful Links

International Liver Congress™ 2017
Updates On This Blog

Slides available @ NATAP

Meeting Updates & Videos

Meeting Updates
Medpage Today

Liver Cancer
Oncology Conference Multimedia

Abstract Book
Journal Of Hepatology

EASL YouTube Channel
Published on April 20
ILC 2017 - Press conference 1
HCV Post SVR Management and Complications

EASL In The Press
Press Room

HIV and Hepatitis

Of Interest
Published on Apr 20
Raquel Peck, CEO World Hepatitis Alliance, speaks at opening ceremony at EASL's International Liver Congress April 2017. She casts the wide vision of worldwide hepatitis elimination, and challenges medical professionals to be partners in the effort. And she shares a bit of her own amazing story.

HCV Resource Links
Premier Hepatitis C Websites, Blogs and Support Forums